tiprankstipranks
Advertisement
Advertisement
PTC Therapeutics price target raised to $94 from $92 at Morgan Stanley
PremiumThe FlyPTC Therapeutics price target raised to $94 from $92 at Morgan Stanley
11d ago
PTC Therapeutics upgraded to Buy from Hold at TD Cowen
Premium
The Fly
PTC Therapeutics upgraded to Buy from Hold at TD Cowen
11d ago
PTC Therapeutics reports Q1 EPS (3c) vs. ($10.04) last year
Premium
The Fly
PTC Therapeutics reports Q1 EPS (3c) vs. ($10.04) last year
11d ago
PTC Therapeutics reports ‘positive’ results from PIVOT-HD study
PremiumThe FlyPTC Therapeutics reports ‘positive’ results from PIVOT-HD study
20d ago
PTCT Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
PTCT Earnings this Week: How Will it Perform?
28d ago
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
Premium
The Fly
Hemmati eyed for top vaccine and gene therapy regulator role, Bloomberg says
1M ago
PTC Therapeutics assumed at Hold from Buy at Jefferies
PremiumThe FlyPTC Therapeutics assumed at Hold from Buy at Jefferies
2M ago
PTC Therapeutics Adds Veteran Banker to Board
Premium
Company Announcements
PTC Therapeutics Adds Veteran Banker to Board
2M ago
Controversial Prasad leaving FDA, NYT reports
Premium
The Fly
Controversial Prasad leaving FDA, NYT reports
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100